At Ember, we have designed a team based, collaborative approach to the mental health and wellbeing of our patients. We aim to work alongside a vibrant partner community of psychiatrists, therapists, primary care physicians, and other caring providers, to help our patients get the most from ketamine treatment.
Below, please find a set of resources we’ve crafted to foster this collaboration.
At Ember, we often talk about the “three part framework” of how ketamine works to treat depression. We have in fact designed our model of care and partnership to maximize each of these three, distinct benefits. This article outlines the evidence and resources that speak to these three impacts.
At Ember, we’ve designed all elements of our care model to maximize the distinct benefits of ketamine for depression. This has resulted in a commitment to an evidence-based, patient-centered, partner-driven care model. In this article, we discuss why we believe these pillars are fundamental to delivering the gold standard of care in our field.
Our patients consistently tell us how important it is to thoughtfully prepare for their ketamine treatments. We’ve provided guidelines that you can reference to help your patients prepare both emotionally and logistically for their initial sessions with us at Ember. We provided these same resources to each patient, and encourage them to work with their mental health team to discuss in advance of their first infusion.
At Ember Health, we defer to the expertise of each patient’s prescribing practitioners for all medication decision-making outside of our ketamine administration. Our goal is to ensure that our partners are fully informed about how their decision can impact our treatments, so that they can knowledgeably help our shared patients navigate their goals of care.
This article considers the interaction of various medications on ketamine, and introduces preliminary guidelines for prescribing partners whose patients want to consider a change in their medications routines over time.
IV ketamine treatment offers a highly effective and safe way to address depressive symptoms over time. That said, it is not a “cure.” For the nearly 90% of people who realize improvements in their depressive symptoms, those positive effects usually last between 2 - 16 weeks before depressive symptoms return, and booster infusions are needed to maintain mental health goals over time. This article outlines the various stages of care and how we engage with patients and their provider partners over time to realize each patient’s care goals.
At Ember Health, we have designed an in-office treatment experience to ensure clinical and psychological safety, and maximize the potential for positive patient outcomes. This article outlines how patients spend their 90-minute appointment at Ember Health, and how patients have described the altered states they experience during the ketamine infusion.
Patients tell us time and again how important it is to have dedicated time to “integrate” the psychological content that comes up during their sessions, take stock of how they are feeling, and make the most of the neuroplastic window following care. This article outlines the opportunity mental health providers have to help patients work through the emergent content and extend the length of mental “durability” between sessions.
This article explains the three elements we use to evaluate the degree to which a patient has responded to their ketamine treatment: a patient’s quantitative response to PHQ9 surveys, the patient’s qualitative feedback, and the clinical assessment of their independent mental health provider.
Literature supports that ketamine treatment produces a period of increased neuroplasticity, which presents the opportunity for patients to engage in adaptive learning following treatment. In this article, we explain this phenomenon and the powerful role providers play to help patients make the most of the neuroplastic window to fulfill long term care goals.
